![Michael Thomas Boyce-Jacino](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Thomas Boyce-Jacino
Directeur Général chez
QLIDA Diagnostics, Inc.
Profil
Michael Thomas Boyce-Jacino is the founder of QLIDA Diagnostics, Inc. Current jobs include President, Chief Executive Officer & Director at Aptatek Biosciences, Inc. and Director at Princeton Biostrategy Group LLP.
Former jobs include President & Chief Executive Officer at Bionano Genomics, Inc., Chief Executive Officer at Vortex BioSciences, Inc., VP & Director-Global Genomics Research at Beckman Coulter, Inc., Director at PDS Operating Corp., Director at Dalian Wanda Group Co., Ltd., Executive Director at EMV Capital Plc from 2013 to 2015, Director at Optofluidics, Inc., Director at Glycotest, Inc., Chief Scientific Officer, Vice President & GM at Orchid Cellmark, Inc., and President at Molecular Tool, Inc. Education includes an undergraduate degree from the University of Wisconsin and a doctorate from the University of Minnesota.
Postes actifs de Michael Thomas Boyce-Jacino
| Sociétés | Poste | Début |
|---|---|---|
QLIDA Diagnostics, Inc.
 QLIDA Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops and manufactures biomarker diagnostic tests | Directeur Général | - |
Princeton Biostrategy Group LLP | Directeur/Membre du Conseil | - |
Aptatek Biosciences, Inc.
 Aptatek Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops portable disease management devices | Directeur Général | - |
Anciens postes connus de Michael Thomas Boyce-Jacino
| Sociétés | Poste | Fin |
|---|---|---|
| EMV CAPITAL PLC | Directeur des opérations | - |
Vortex BioSciences, Inc.
 Vortex BioSciences, Inc. Medical SpecialtiesHealth Technology Develops a novel liquid biopsy automated instrument and micro fluidic cartridge for the isolation of circulating tumor cells | Directeur Général | 31/12/2015 |
Glycotest, Inc.
 Glycotest, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops unique and non-invasive blood tests for liver cancers and fibrosis-cirrhosis | Directeur/Membre du Conseil | - |
Dalian Wanda Group Co., Ltd.
 Dalian Wanda Group Co., Ltd. Real Estate DevelopmentFinance Provides real estate and investment services | Directeur/Membre du Conseil | - |
Molecular Tool, Inc.
 Molecular Tool, Inc. Packaged SoftwareTechnology Services Develops tools for analysis of DNA sequence variation | President | - |
Formation de Michael Thomas Boyce-Jacino
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
9
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Beckman Coulter, Inc.
 Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes biomedical testing instrument systems and general biomedical research products | Health Technology |
Orchid Cellmark, Inc.
 Orchid Cellmark, Inc. Miscellaneous Commercial ServicesCommercial Services Provides DNA testing services | Commercial Services |
PDS Operating Corp.
 PDS Operating Corp. Pharmaceuticals: MajorHealth Technology Develops novel cancer immunotherapies and vaccines for infectious disease | Health Technology |
Molecular Tool, Inc.
Molecular Tool, Inc. Packaged SoftwareTechnology Services Develops tools for analysis of DNA sequence variation | Technology Services |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dalian Wanda Group Co., Ltd.
Dalian Wanda Group Co., Ltd. Real Estate DevelopmentFinance Provides real estate and investment services | Finance |
Bionano Genomics, Inc.
 Bionano Genomics, Inc. BiotechnologyHealth Technology Develops technologies for analysis of large biological molecules | Health Technology |
EMV Capital Plc
 EMV Capital Plc Medical SpecialtiesHealth Technology Identifies, develops and commercializes transformative biomedical & healthcare technologies | Health Technology |
Optofluidics, Inc.
 Optofluidics, Inc. Medical SpecialtiesHealth Technology Develops imaging technologies to detect, identify and count interfering materials in therapeutic products | Health Technology |
QLIDA Diagnostics, Inc.
QLIDA Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops and manufactures biomarker diagnostic tests | Health Technology |
Princeton Biostrategy Group LLP | |
Vortex BioSciences, Inc.
Vortex BioSciences, Inc. Medical SpecialtiesHealth Technology Develops a novel liquid biopsy automated instrument and micro fluidic cartridge for the isolation of circulating tumor cells | Health Technology |
Glycotest, Inc.
Glycotest, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops unique and non-invasive blood tests for liver cancers and fibrosis-cirrhosis | Electronic Technology |
Aptatek Biosciences, Inc.
Aptatek Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops portable disease management devices | Electronic Technology |
